Raymond J. Henley Iii

Array ( [id] => 4252421 [patent_doc_number] => 06207682 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Modified release formulations containing (R)-1-(10,11-dihydro-5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1propyl)-3-pipe ridinecarboxylic acid' [patent_app_type] => 1 [patent_app_number] => 9/469135 [patent_app_country] => US [patent_app_date] => 1999-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3404 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207682.pdf [firstpage_image] =>[orig_patent_app_number] => 469135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4375556 [patent_doc_number] => 06261542 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Composition for protecting the skin or the hair, containing nanopigments and a solid elastomeric polyorganosiloxane combined with a fatty phase' [patent_app_type] => 1 [patent_app_number] => 9/467002 [patent_app_country] => US [patent_app_date] => 1999-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3365 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/261/06261542.pdf [firstpage_image] =>[orig_patent_app_number] => 467002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4175471 [patent_doc_number] => 06083993 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Method for treating bronchospasm using optically pure R(-) albuterol' [patent_app_type] => 1 [patent_app_number] => 9/466107 [patent_app_country] => US [patent_app_date] => 1999-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1317 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083993.pdf [firstpage_image] =>[orig_patent_app_number] => 466107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1494548 [patent_doc_number] => 06342495 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Agonists and antagonists of peripheral-type benzodiazepine receptors' [patent_app_type] => B1 [patent_app_number] => 09/461780 [patent_app_country] => US [patent_app_date] => 1999-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15696 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342495.pdf [firstpage_image] =>[orig_patent_app_number] => 09461780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4315073 [patent_doc_number] => 06242479 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Use of .gamma.-tocopherol and its oxidative metabolite LLU-.alpha. in the treatment of disease' [patent_app_type] => 1 [patent_app_number] => 9/461645 [patent_app_country] => US [patent_app_date] => 1999-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14974 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242479.pdf [firstpage_image] =>[orig_patent_app_number] => 461645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4157584 [patent_doc_number] => 06156735 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Arginine silicate inositol complex and use thereof' [patent_app_type] => 1 [patent_app_number] => 9/367267 [patent_app_country] => US [patent_app_date] => 1999-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3738 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156735.pdf [firstpage_image] =>[orig_patent_app_number] => 367267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4304138 [patent_doc_number] => 06187743 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Composition and method for enhancing wound healing' [patent_app_type] => 1 [patent_app_number] => 9/459753 [patent_app_country] => US [patent_app_date] => 1999-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11644 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187743.pdf [firstpage_image] =>[orig_patent_app_number] => 459753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4356948 [patent_doc_number] => 06201014 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-13 [patent_title] => 'Therapeutically active compositions' [patent_app_type] => 1 [patent_app_number] => 9/445514 [patent_app_country] => US [patent_app_date] => 1999-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3899 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/201/06201014.pdf [firstpage_image] =>[orig_patent_app_number] => 445514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4237424 [patent_doc_number] => 06143741 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells' [patent_app_type] => 1 [patent_app_number] => 9/230941 [patent_app_country] => US [patent_app_date] => 1999-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 16 [patent_no_of_words] => 7801 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 350 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143741.pdf [firstpage_image] =>[orig_patent_app_number] => 230941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4119038 [patent_doc_number] => 06071933 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'Homogeneous remifentanil-propofol blend for patient controlled anesthesia and process for its use' [patent_app_type] => 1 [patent_app_number] => 9/452860 [patent_app_country] => US [patent_app_date] => 1999-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2675 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/071/06071933.pdf [firstpage_image] =>[orig_patent_app_number] => 452860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1495460 [patent_doc_number] => 06403579 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Pharmaceutical compositions containing carvedilol and hydrochlorothiazide' [patent_app_type] => B1 [patent_app_number] => 09/447872 [patent_app_country] => US [patent_app_date] => 1999-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4406 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403579.pdf [firstpage_image] =>[orig_patent_app_number] => 09447872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4421790 [patent_doc_number] => 06225315 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'Method of treating nitrate-induced tolerance' [patent_app_type] => 1 [patent_app_number] => 9/442821 [patent_app_country] => US [patent_app_date] => 1999-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10920 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/225/06225315.pdf [firstpage_image] =>[orig_patent_app_number] => 442821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4097548 [patent_doc_number] => 06099868 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Method of using potassium nitrate for pain reduction' [patent_app_type] => 1 [patent_app_number] => 9/439858 [patent_app_country] => US [patent_app_date] => 1999-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4385 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/099/06099868.pdf [firstpage_image] =>[orig_patent_app_number] => 439858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4260591 [patent_doc_number] => 06204270 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Ophthalmic and mucosal preparations' [patent_app_type] => 1 [patent_app_number] => 9/439636 [patent_app_country] => US [patent_app_date] => 1999-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2274 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204270.pdf [firstpage_image] =>[orig_patent_app_number] => 439636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288132 [patent_doc_number] => 06211165 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists' [patent_app_type] => 1 [patent_app_number] => 9/423129 [patent_app_country] => US [patent_app_date] => 1999-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 41 [patent_no_of_words] => 9505 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/211/06211165.pdf [firstpage_image] =>[orig_patent_app_number] => 423129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4231324 [patent_doc_number] => 06143332 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Nutritional supplement for the prevention and treatment of excessive intestinal permeability' [patent_app_type] => 1 [patent_app_number] => 9/431724 [patent_app_country] => US [patent_app_date] => 1999-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5057 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143332.pdf [firstpage_image] =>[orig_patent_app_number] => 431724 [rel_patent_id] =>[rel_patent_doc_number] =>)